Epidemiological Trends and Age-period-cohort Effects on Lip and Oral Cavity Cancer Burden Across the BRICS from 1992 to 2021

Overview

Journal Front Oncol

Specialty Oncology

Date 2025 Mar 4

PMID 40034600

Authors

Zhengrong Yu

Yuhang Wu

Yu Cao

Peiyu Cheng

Affiliations

Soon will be listed here.

Abstract

Background: Lip and oral cavity cancer (LOC) is one of the common malignant tumors of the head and neck, posing significant health and economic burdens. The BRICS, including Brazil, Russia, India, China, and South Africa, represent a large global population, presenting unique public health challenges. This study aims to evaluate the epidemiological trends and variations in the burden of LOC across BRICS in a timely manner.

Methods: Data on the number, all-age rate, age-standardized rate, and relative change in LOC incidence from 1992 to 2021 within BRICS were obtained from the Global Burden of Disease study (GBD) 2021, and we analyzed global and BRICS-specific LOC incidence trends over 30 years. Furthermore, age-period-cohort model was applied to estimate net drift, local drift, age, period and cohort effects between 1992 and 2021.

Results: In 2021, the BRICS nations reported 194.74 thousand new LOC cases, constituting 46.2% of the global total. From 1992 to 2021, all BRICS countries witnessed a significant rise in LOC cases, with China leading at 259.06%. The age-standardized incidence of LOC increased by over 20% in the Russian Federation, India, and China, while Brazil and South Africa exhibited marginal changes (Brazil: 0.75%; South Africa: -7.87%). Rising LOC trends were prevalent across most age groups in China, India, and the Russian Federation, particularly affecting older adults (60-94 years). Age, period, and cohort effects were deteriorating in China and India, contrasting with improvements in Brazil and South Africa.

Conclusion: LOC incidence has increased across BRICS, with temporal trends not consistently aligning with economic growth and exhibiting significant variation among countries. Brazil's experience highlights the efficacy of oral health and tobacco control measures in mitigating LOC, especially in fast-developing nations. Prevention should target men and elderly in China and India, and women in other areas.

References

. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440):2100-2132. PMC: 11126520. DOI: 10.1016/S0140-6736(24)00367-2. View

Harris M, Phillips D, Sayer J, Moore M . A comparison of community-based and hospital-based head and neck cancer screening campaigns: identifying high-risk individuals and early disease. JAMA Otolaryngol Head Neck Surg. 2013; 139(6):568-73. DOI: 10.1001/jamaoto.2013.3153. View

Cunha A, Prass T, Hugo F . Mortality from oral and oropharyngeal cancer in Brazil: impact of the National Oral Health Policy. Cad Saude Publica. 2019; 35(12):e00014319. DOI: 10.1590/0102-311X00014319. View

Michaelsen S, Gronhoj C, Hoxbroe Michaelsen J, Friborg J, von Buchwald C . Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017; 78:91-102. DOI: 10.1016/j.ejca.2017.03.006. View

Zhao X, Davey G . Areca Nut Use among a Chinese Ethnic Minority, and Its Health Implications. Subst Use Misuse. 2019; 55(9):1519-1524. DOI: 10.1080/10826084.2019.1660676. View

Romagna D, Oliveira M, Abreu L, Stein C, Hugo F, Teixeira R . Incidence and mortality rates of lip, oral cavity, and pharynx cancers in Brazil: time-trend and age-period-cohort analysis from the last 30 years, Global Burden of Disease Study. Rev Soc Bras Med Trop. 2022; 55(suppl 1):e0286. PMC: 9009427. DOI: 10.1590/0037-8682-0286-2021. View

Pucca Jr G, Gabriel M, de Araujo M, de Almeida F . Ten Years of a National Oral Health Policy in Brazil: Innovation, Boldness, and Numerous Challenges. J Dent Res. 2015; 94(10):1333-7. DOI: 10.1177/0022034515599979. View

Mishra S, Joseph R, Gupta P, Pezzack B, Ram F, Sinha D . Trends in bidi and cigarette smoking in India from 1998 to 2015, by age, gender and education. BMJ Glob Health. 2017; 1(1):e000005. PMC: 5321300. DOI: 10.1136/bmjgh-2015-000005. View

Hashim D, Genden E, Posner M, Hashibe M, Boffetta P . Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019; 30(5):744-756. PMC: 6551449. DOI: 10.1093/annonc/mdz084. View

10.

Flor L, Reitsma M, Gupta V, Ng M, Gakidou E . The effects of tobacco control policies on global smoking prevalence. Nat Med. 2021; 27(2):239-243. PMC: 7884287. DOI: 10.1038/s41591-020-01210-8. View

11.

De Vuyst H, Alemany L, Lacey C, Chibwesha C, Sahasrabuddhe V, Banura C . The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013; 31 Suppl 5:F32-46. PMC: 4144870. DOI: 10.1016/j.vaccine.2012.07.092. View

12.

Sahoo P, Rout H, Jakovljevic M . Future health expenditure in the BRICS countries: a forecasting analysis for 2035. Global Health. 2023; 19(1):49. PMC: 10334532. DOI: 10.1186/s12992-023-00947-4. View

13.

Winkler V, Mangolo N, Becher H . Lung cancer in South Africa: a forecast to 2025 based on smoking prevalence data. BMJ Open. 2015; 5(3):e006993. PMC: 4368914. DOI: 10.1136/bmjopen-2014-006993. View

14.

Fan L, Wu Y, Wei J, Xia F, Cai Y, Zhang S . Global, regional, and national time trends in incidence for migraine, from 1990 to 2019: an age-period-cohort analysis for the GBD 2019. J Headache Pain. 2023; 24(1):79. PMC: 10314517. DOI: 10.1186/s10194-023-01619-9. View

15.

Kumar M, Nanavati R, Modi T, Dobariya C . Oral cancer: Etiology and risk factors: A review. J Cancer Res Ther. 2016; 12(2):458-63. DOI: 10.4103/0973-1482.186696. View

16.

Fan K, Rimal J, Zhang P, Johnson N . Stark differences in cancer epidemiological data between GLOBOCAN and GBD: Emphasis on oral cancer and wider implications. EClinicalMedicine. 2022; 54:101673. PMC: 9561675. DOI: 10.1016/j.eclinm.2022.101673. View

17.

Lima I, Almeida R, Pontes-Silva A, Ribeiro B, Figueiredo F, Quaresma F . Epidemiological study on the lip and oral cavity cancer in Brazil: connecting science and clinical applicability. Rev Assoc Med Bras (1992). 2022; 68(9):1337-1341. PMC: 9575038. DOI: 10.1590/1806-9282.20220806. View

18.

Muntyanu A, Nechaev V, Pastukhova E, Logan J, Rahme E, Zubarev A . Burden and geographic distribution of oral cavity and oropharyngeal cancers in the Russian Federation. Front Oncol. 2023; 13:1197287. PMC: 10435750. DOI: 10.3389/fonc.2023.1197287. View

19.

Kocarnik J, Compton K, Dean F, Fu W, Gaw B, Harvey J . Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2021; 8(3):420-444. PMC: 8719276. DOI: 10.1001/jamaoncol.2021.6987. View

20.

Cunha A, Compton K, Xu R, Mishra R, Drangsholt M, Antunes J . The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2023; 9(10):1401-1416. PMC: 10485745. DOI: 10.1001/jamaoncol.2023.2960. View